image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

RWS - Acquisition improves patent translator’s eps growth prospects

July 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RWS
  • Price:
  • 480p
AIM-listed RWS, the leading provider of patent translation and other search services, has chiselled out a highly lucrative niche for itself with sales and pretax profit increasing from £31m and £6m to £65.1m and £16.2m respectively in the past seven years. As you might expect the shares have responded with a stellar climb from a placing price of 112.5p back in November 2003 to a high earlier this year of 560p, before going into remission in the market turbulence. The vast majority of RWS' business comprises translation services of which patent translation (70% divisional sales) is the most significant. Operating through offices in Europe, New York, Beijing and Tokyo RWS translates more than 65,000 patents and intellectual prop ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X